LarryDCripeMD
Oncology • Indianapolis, INAssociate Professor, Medicine, Indiana University School of Medicine
Dr. Cripe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
535 Barnhill Dr
# ROUTE473
Indianapolis, IN 46202Phone+1 317-278-1186Fax+1 317-944-2181
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1987 - 1990
Rush University Medical CenterResidency, Internal Medicine, 1984 - 1987
Rush Medical College of Rush University Medical CenterClass of 1984
Certifications & Licensure
IN State Medical License 1995 - 2025
NC State Medical License 1987 - 1998
MI State Medical License 1993 - 1997
IL State Medical License 1985 - 1987- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Indianapolis Monthly Castle Connolly, 2013
- Top MD Consumers Checkbook
Clinical Trials
- Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia Start of enrollment: 2002 Sep 17
- Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes Start of enrollment: 2006 Sep 01
- Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease Start of enrollment: 2007 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- The Goal Inventory: An Innovative Digital Resource to Help Patients Identify and Evaluate Their Goals.Larry D Cripe, Ann H Cottingham, Patrick O Monahan, Timothy E Stump, Miranda G Shuler
Journal of Pain and Symptom Management. 2024-10-01 - 2 citationsChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyWilliam G Wierda, Jennifer Brown, Jeremy S Abramson, Farrukh Awan, Syed F Bilgrami
Journal of the National Comprehensive Cancer Network. 2024-04-01 - 2 citationsObesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis.James M Foran, Zhuoxin Sun, Catherine Lai, Hugo F Fernandez, Larry D Cripe
Cancer. 2023-08-15
Press Mentions
NCCN Awards Grants to Improve Care for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaDecember 4th, 2024- Chuckstrong Tailgate Gala Raises More Than $2 Million, Marking a Decade of Dedication to IU Cancer ResearchAugust 5th, 2022
- Cancer Interrupted Campus ‘Dad’s Weekend’ for Devoted FatherOctober 3rd, 2021
- Join now to see all
Grant Support
- Single-Center Phase I Study To Determine The Optimal Biologic Dose Of Cc-401National Center For Research Resources2007–2008
- Zosuquidar Trihydrochloride During Conventional Induction And Post-RemissionNational Center For Research Resources2006
- Clinical Research OfficeNational Cancer Institute2004
- Ly335979, Daunorubicin, Cytarabine In Myelogenous LeukemNational Center For Research Resources2000–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
